AstraZeneca Pharma India has received approval from the CDSO for the import, sale, and distribution of Durvalumab.

With the Nifty approaching 26,000, the Indian stock market is bullish, particularly in the power sector. Key players NTPC, ...

NTPC Ltd. 532555 shares inched down 0.07% to 428.00 Indian rupees Tuesday, on what proved to be an all-around poor trading ...

Welcome to the NTPC Stock Liveblog, your ultimate source for real-time updates and analysis of one of the most prominent ...

The Tata Power target price has been set at Rs 530, with a 'buy' rating that reflects a potential upside of 19%.

The stock jumped more than 12% to hit its lifetime high of Rs 7,598. The surge was as the company received Central Drugs ...

Ntpc share price has gained 0.22% today to trade at ₹429.25 in resonance with its peers. Its peers such as are also on the rise. Overall, benchmark indices Nifty & Sensex are up 0.05% & 0.07% each ...

In the last 2 years, all major selling in the BHEL stock has ended at its 200-day EMA levels. In the current instance too, ...

Gift Nifty is trading at a premium of about 50 points compared to Nifty Futures Monday wrap up, indicating that the Asian ...

Welcome to the NTPC Stock Liveblog, your go-to platform for real-time updates and analysis on a top-performing stock. Stay ...

NTPC Green Energy aims to raise Rs 10,000 crore through this public issue, which will consist solely of a fresh issue without ...

The domestic equity benchmarks continued their winning streak on Monday, closing with decent gains for the third consecutive day. The benchmark Nifty index settled above the 25,900 level, buoyed by a ...